CN Stock MarketDetailed Quotes

600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.

Watchlist
  • 19.97
  • +0.02+0.10%
Noon Break Dec 5 11:29 CST
9.34BMarket Cap86.83P/E (TTM)

About Vcanbio Cell & Gene Engineering Corp.,Ltd. Company

The company is an innovative life science enterprise with the vision of “precision medicine for the benefit of humanity”. The company focuses on the three major sectors of “precise prevention”, “accurate diagnosis” and “cell therapy”. Its main business covers the “precision medicine” industry chain, such as preparation and storage of cell testing, preparation and storage of in vitro diagnostic materials, in vitro diagnostic reagents and devices, scientific research reagent products such as biogenes, proteins, antibodies, etc., genetic testing services, and research and development of clinical applications of stem cells and immune cells. The company has advanced cell technology and a national cell resource storage network, and is one of the country's important cell technology product development and transformation bases. The company's main business includes preparation and storage of cell tests in the field of “precision prevention”; research and production of in vitro diagnostic materials, in vitro diagnostic reagents and devices in the field of “accurate diagnosis”, scientific research reagent products such as biogenes, proteins, antibodies, etc., and genetic testing services; research and development of clinical applications of stem cells and immune cells in the field of “precision therapy”; forming a “precision medicine” industry chain. The main products and services include: cell test preparation and storage services, in vitro diagnosis services: R&D, production, sales, and genetic testing services for in vitro diagnostic materials, biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental complexes, including monoclonal antibodies and polyclonal antibody products. Company honors include the Vice Chairman Unit of the National Stem Cell and Regenerative Medicine Industry Technology Innovation Strategic Alliance, the Vice Chairman Unit of the Regenerative Medicine Professional Committee of the China Pharmaceutical Biotechnology Association, and the Blood Station Practice License.

Company Profile

Short Name-A中源协和
Symbol-A600645
Company NameZhongyuan Union Cell & Gene Engineering Corp., Ltd
Listing DateMay 4, 1993
Issue Price5.00
Shares Offered12.00M share(s)
FoundedJun 14, 1995
Listed ExchangeSH Stock Exchange
Legal Representativehongqi wang
General Managerhongqi wang
Secretaryxinzhe yang
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativefen zhang
Legal CounselBeijing Guofeng Law Firm
Employees112
Phone022-58617160
Office AddressNo. 12 Meiyuan Road, Huayuan Industrial Zone, Binhai High-tech Zone, Tianjin
Zip Code300384
Registered AddressTwo-story house, block [A], No. 12, Meiyuan Road, Huayuan Industrial Zone, Binhai High-tech Zone, Tianjin
Fax022-58617161
Emailzhongyuanxiehe@vcanbio.com
Business License120000000008313
BusinessGeneral projects: medical research and experimental development; engineering and technical research and experimental development; human stem cell technology development and application; cell technology development and application; technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; human genetic diagnosis and treatment technology development; cosmetics wholesale; cosmetics retail; first-class medical device sales. Engage in investment activities with own funds; domestic trade agency; import and export of goods; import and export of technology. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with the law)

Company Executives

  • Name
  • Position
  • Salary
  • hongjia gong
  • Chairman, Directors, Member of the Remuneration and Assessment Committee, Chairman of the Strategy Committee, Nomination Committee Members
  • --
  • hongqi wang
  • Vice Chairman, Directors, General Manager, Strategy Committee Member
  • 419.30K
  • yong wang
  • Vice Chairman, Directors, Strategy Committee Member
  • 1.93M
  • shan wu
  • Directors, Audit Committee Member
  • --
  • xu li
  • Directors, Deputy General Manager, Strategy Committee Member
  • 1.07M
  • haibin li
  • Directors, Deputy General Manager
  • 1.06M
  • xinyi hou
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
  • 100.00K
  • mingsheng luo
  • Independent Directors, Nomination Committee Members, Chairman of the Audit Committee
  • 62.90K
  • duanqing pei
  • Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member, Member of the Remuneration and Assessment Committee
  • 100.00K
  • xinzhe yang
  • Board Secretary, Deputy General Manager
  • 1.02M
  • fen zhang
  • Securities Affairs Representative
  • --
  • yan wang
  • Chairman of the Supervisory Board, Auditors
  • --
  • xintong li
  • Auditors
  • --
  • jiali zhou
  • Deputy General Manager
  • 977.30K
  • hongxiang shi
  • Deputy General Manager
  • 1.06M
  • yu zhang
  • Deputy General Manager
  • 2.42M
  • yiqing chen
  • Deputy General Manager, Chief Financial Officer
  • --
  • tianyi li
  • Employee Supervisors
  • 191.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data